Epithalon (Epitalon) and NAD+ precursors (NMN, NR) are two of the most studied compounds in longevity research. Epithalon works primarily through telomerase activation and pineal gland regulation, while NAD+ precursors address mitochondrial function and sirtuin activation. The two mechanisms are complementary and address different hallmarks of aging.
Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly) that activates telomerase, the enzyme responsible for maintaining telomere length. It also regulates melatonin production via the pineal gland and has antioxidant properties. NAD+ precursors (NMN, NR) raise intracellular NAD+ levels, which decline with age. NAD+ is a cofactor for sirtuins (SIRT1-7) and PARP enzymes involved in DNA repair, mitochondrial biogenesis, and metabolic regulation.
Epithalon has demonstrated telomere elongation in human cell cultures and life extension in animal models. Clinical studies in elderly patients showed improvements in melatonin levels and immune function. NAD+ precursors have been studied in multiple human trials showing improvements in muscle function, metabolic markers, and NAD+ levels. No direct combination studies exist.
Epithalon is typically studied in short courses (10–20 days, 1–2 times per year) due to its mechanism of action. NAD+ precursors are generally taken daily. The two can be used concurrently — Epithalon courses can be run while maintaining daily NAD+ precursor supplementation.
Both compounds have favorable safety profiles in available research. Epithalon has been studied in elderly human populations without significant adverse effects. NAD+ precursors are well-tolerated at standard doses. No known interactions between the two compounds have been identified.
The combination addresses two distinct hallmarks of aging — telomere shortening (Epithalon) and mitochondrial decline (NAD+). Many longevity researchers consider them complementary rather than redundant, making the combination logical for comprehensive anti-aging protocols.
Not directly. Epithalon's primary mechanism is telomerase activation and pineal regulation. NAD+ precursors (NMN, NR) are the appropriate intervention for raising intracellular NAD+ levels.
Epithalon is typically cycled (10–20 days on, several months off). NAD+ precursors are generally taken daily year-round. The Epithalon courses can be layered on top of the daily NAD+ protocol.
Common additions to an Epithalon + NAD+ protocol include Rapamycin (mTOR inhibition), Metformin (AMPK activation), and GHK-Cu (collagen and antioxidant support). Each addresses a different longevity pathway.
Purgo Labs provides research-grade peptides with independent third-party COAs and >99% purity verification.
Shop Purgo Labs